| 1 |
Anderson JL, Morrow DA. Acute myocardial infarction [J]. N Engl J Med, 2017, 376(21): 2053-2064.
|
| 2 |
Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury [J]. Cardiovasc Res, 2004, 61(3): 427-436.
|
| 3 |
胡盛寿, 高润霖, 刘力生, 等. 《中国心血管病报告2018》概要 [J]. 中国循环杂志, 2019, 34(3): 209-220.
|
| 4 |
Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction [J]. J Am Coll Cardiol, 2000, 36(4): 1202-1209.
|
| 5 |
Guadall A, Orriols M, Alcudia JF, et al. Hypoxia-induced ROS signaling is required for LOX up-regulation in endothelial cells [J]. Front Biosci (Elite Ed), 2011, 3: 955-967.
|
| 6 |
Van Leyen K, Kim HY, Lee SR, et al. Baicalein and 12/15-lipoxygenase in the ischemic brain [J]. Stroke, 2006, 37(12): 3014-3018.
|
| 7 |
Kain V, Ingle KA, Kabarowski J, et al. Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction [J]. J Mol Cell Cardiol, 2018, 118: 70-80.
|
| 8 |
Song L, Yang H, Wang HX, et al. Inhibition of 12/15 lipoxygenase by baicalein reduces myocardialischemia/reperfusioninjury via modulation of multiple signaling pathways [J]. Apoptosis, 2014, 19(4):567-580.
|
| 9 |
Funk CD, Chen XS, Johnson EN, et al. Lipoxygenase genes and their targeted disruption [J]. Prostaglandins Other Lipid Mediat, 2002, 68-69: 303-312.
|
| 10 |
Ivanov I, Kuhn H, Heydeck D. Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15) [J]. Gene, 2015, 573(1): 1-32.
|
| 11 |
谭震, 厉小梅. 12/15-脂氧合酶对骨质疏松的影响 [J]. 中华骨质疏松和骨矿盐疾病杂志, 2013, 6(3): 89-92.
|
| 12 |
Kayama Y, Minamino T, Toko H, et al. Cardiac 12/15 lipoxygenase-induced inflammation is involved in heart failure [J]. J Exp Med, 2009, 206(7):1565-1574.
|
| 13 |
Reilly KB, Srinivasan S, Hatley ME, et al. 12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo [J]. J Biol Chem, 2004, 279(10): 9440-9450.
|
| 14 |
Suzuki H, Kayama Y, Sakamoto M, et al. Arachidonate 12/15-lipoxygenase-induced inflammation and oxidative stress areinvolved in the development of diabetic cardiomyopathy [J]. Diabetes, 2015, 64(2): 618-630.
|
| 15 |
Zhao L, Funk CD. Lipoxygenase pathways in atherogenesis [J]. Trends Cardiovasc Med, 2004, 14(5): 191-195.
|
| 16 |
Sears DD, Miles PD, Chapman J, et al. 12/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice [J]. PLoS One, 2009, 4(9): e7250.
|
| 17 |
Wen Y, Gu J, Chakrabarti SK, et al. The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages [J]. Endocrinology, 2007, 148(3): 1313-1322.
|
| 18 |
Zhao L, Cuff CA, Moss E, et al. Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia [J]. J Biol Chem, 2002, 277(38): 35350-35356.
|
| 19 |
Chan MM, Moore AR. Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production [J]. J Immunol, 2010, 184(11): 6418-6426.
|
| 20 |
Lindley AR, Crapster-Pregont M, Liu Y, et al. 12/15-lipoxygenase is an interleukin-13 and interferon-γ counterregulated-mediator of allergic airway inflammation [J]. Mediators Inflamm, 2010, 2010: 727305.
|
| 21 |
Kalogeris T, Baines CP, Krenz M, et al. Ischemia/reperfusion [J]. Compr Physiol, 2016, 7(1): 113-170.
|
| 22 |
Han J, Sun L, Xu Y, et al. Activation of PPARγ by 12/15-lipoxygenase during cerebral ischemia-reperfusion injury [J]. Int J Mol Med, 2015, 35(1): 195-201.
|
| 23 |
Czapski GA, Czubowicz K, Strosznajder RP. Evaluation of the antioxidative properties of lipoxygenase inhibitors [J]. Pharmacol Rep, 2012, 64(5): 1179-1188.
|
| 24 |
Praticò D, Zhukareva V, Yao Y, et al. 12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress [J]. Am J Pathol, 2004, 164(5): 1655-1662.
|
| 25 |
Anning PB, Coles B, Bermudez-Fajardo A, et al. Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice [J]. Am J Pathol, 2005, 166(3): 653-662.
|
| 26 |
DelliPizzi A, Guan H, Tong X, et al. Lipoxygenase-dependent mechanisms in hypertension [J]. Clin Exp Hypertens, 2000, 22(2): 181-192.
|
| 27 |
Li Q, Li QQ, Jia JN, et al. Baicalein exerts neuroprotective effects in FeCl3-induced posttraumatic epileptic seizures via suppressing ferroptosis [J]. Front Pharmacol, 2019, 10: 638.
|
| 28 |
Del Re DP, Amgalan D, Linkermann A, et al. Fundamental mechanisms of regulated cell death and implications for heart disease [J]. Physiol Rev, 2019, 99(4): 1765-1817.
|
| 29 |
Sakamoto M, Minamino T, Toko H, et al. Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy [J]. Circ Res, 2006, 99(12): 1411-1418.
|
| 30 |
Sano M, Minamino T, Toko H, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload [J]. Nature, 2007, 446(7134): 444-448.
|
| 31 |
Toko H, Takahashi H, Kayama Y, et al. Ca2+/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy [J]. Circulation, 2010, 122(9): 891-899.
|
| 32 |
Natarajan R, Yang DC, Lanting L, et al. Key role of P38 mitogen-activated protein kinase and the lipoxygenase pathway in angiotensin II actions in H295R adrenocortical cells [J]. Endocrine, 2002, 18(3): 295-301.
|
| 33 |
Natarajan R, Nadler JL. Lipid inflammatory mediators in diabetic vascular disease [J]. Arterioscler Thromb Vasc Biol, 2004, 24(9): 1542-1548.
|
| 34 |
Taylor AM, Hanchett R, Natarajan R, et al. The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth [J]. Arterioscler Thromb Vasc Biol, 2005, 25(10): 2069-2074.
|
| 35 |
Zhang Y, Wang Y, Xu J, et al. Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion/mitophagy and activating the AMPK-OPA1 signaling pathways [J]. J Pineal Res, 2019, 66(2): e12542.
|
| 36 |
Dioszeghy V, Rosas M, Maskrey BH, et al. 12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo [J]. J Immunol, 2008, 181(9): 6514-6524.
|
| 37 |
Glass CK, Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells [J]. Nat Rev Immunol, 2010, 10(5): 365-376.
|
| 38 |
Zhao T, Wang D, Cheranov SY, et al. A novel role for activating transcription factor-2 in 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis [J]. J Lipid Res, 2009, 50(3): 521-533.
|
| 39 |
Wen Y, Gu J, Vandenhoff GE, et al. Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages [J]. Am J Physiol Heart Circ Physiol, 2008, 294(4): H1933-H1938.
|
| 40 |
Reddy MA, Sahar S, Villeneuve LM, et al. Role of Src tyrosine kinase in the atherogenic effects ofthe 12/15-lipoxygenase pathway in vascular smooth muscle cells [J]. Arterioscler Thromb Vasc Biol, 2009, 29(3): 387-393.
|
| 41 |
Halade GV, Kain V, Ingle KA, et al. Interaction of 12/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing [J]. Am J Physiol Heart Circ Physiol, 2017, 313(1): H89-H102.
|
| 42 |
Wang AW, Song L, Miao J, et al. Baicalein attenuates angiotensin II-induced cardiac remodeling viainhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice [J]. Am J Hypertens, 2015, 28(4): 518-526.
|
| 43 |
Rajesh M, Mukhopadhyay P, Bátkai S, et al. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy [J]. J Am Coll Cardiol, 2010, 56(25): 2115-2125.
|
| 44 |
Teshima Y, Takahashi N, Nishio S, et al. Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase [J]. Circ J, 2014, 78(2): 300-306.
|
| 45 |
Bugger H, Boudina S, Hu XX, et al. Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3 [J]. Diabetes, 2008, 57(11): 2924-2932.
|
| 46 |
Gorin Y, Block K. Nox as a target for diabetic complications [J]. Clin Sci (Lond), 2013, 125(8): 361-382.
|
| 47 |
Dikalov S. Cross talk between mitochondria and NADPH oxidases [J]. Free Radic Biol Med, 2011, 51(7): 1289-1301.
|
| 48 |
Lee SB, Bae IH, Bae YS, et al. Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death [J]. J Biol Chem, 2006, 281(47): 36228-36235.
|
| 49 |
Frustaci A, Kajstura J, Chimenti C, et al. Myocardial cell death in human diabetes [J]. Circ Res, 2000, 87(12): 1123-1132.
|
| 50 |
Peterson LR, Herrero P, Schechtman KB, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women [J]. Circulation, 2004, 109(18): 2191-2196.
|
| 51 |
Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death [J]. Cell, 2012, 149(5): 1060-1072.
|
| 52 |
Gao M, Monian P, Quadri N, et al. Glutaminolysis and transferrin regulate ferroptosis [J]. Mol Cell, 2015, 59(2): 298-308.
|
| 53 |
Baba Y, Higa JK, Shimada BK, et al. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes [J]. Am J Physiol Heart Circ Physiol, 2018, 314(3): H659-H668.
|
| 54 |
李佳, 邓胜利. 内质网应激在心脏的作用 [J]. 辽宁医学杂志, 2015, 29(6): 321-323.
|
| 55 |
Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy [J]. Proc Natl Acad Sci U S A, 2019, 116(7): 2672-2680.
|
| 56 |
Conrad M, Angeli JP, Vandenabeele P, et al. Regulated necrosis: disease relevance and therapeutic opportunities [J]. Nat Rev Drug Discov, 2016, 15(5): 348-366.
|
| 57 |
Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4 [J]. Cell, 2014, 156(1-2): 317-331.
|
| 58 |
Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition [J]. Nat Chem Biol, 2017, 13(1): 91-98.
|
| 59 |
Probst L, Dächert J, Schenk B, et al. Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death [J]. Biochem Pharmacol, 2017, 140: 41-52.
|
| 60 |
Seiler A, Schneider M, Förster H, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death [J]. Cell Metab, 2008, 8(3): 237-248.
|
| 61 |
Loscalzo J. Membrane redox state and apoptosis: death by peroxide [J]. Cell Metab, 2008, 8(3): 182-183.
|
| 62 |
Drefs M, Thomas MN, Guba M, et al. Modulation of glutathione hemostasis by inhibition of 12/15-lipoxygenase prevents ROS-mediated cell death after hepatic ischemia and reperfusion [J]. Oxid Med Cell Longev, 2017, 2017: 8325754.
|
| 63 |
Park TJ, Park JH, Lee GS, et al. Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes [J]. Cell Death Dis, 2019, 10(11): 835.
|